Brunei Health Wire: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Brunei Health Wire.

Press releases published on August 27, 2026

21 minutes ago

Ambros Therapeutics Announces Appointments of John C. Jacobs and Scott Robertson to Board of Directors

Indeterminate GlobeNewswire

26 minutes ago

Orchestra BioMed to Participate in the H.C. Wainwright 28th Annual Global Investment Conference

Indeterminate GlobeNewswire

26 minutes ago

ICU Medical to Participate in Upcoming Investor Conferences

Indeterminate GlobeNewswire

26 minutes ago

Mental Health America announces Dr. Tia Dole as new president and CEO

Indeterminate GlobeNewswire

26 minutes ago

Propanc Biopharma Announces Compelling New Preclinical Pancreatic Cancer Data for PRP Showing >90% Tumor Growth Inhibition and >2.5-Fold Survival Benefit

Indeterminate GlobeNewswire

37 minutes ago

Biomerica Announces $2.23 Million Financing 

Indeterminate GlobeNewswire

an hour ago

Harmony Biosciences to Participate in 2026 Cantor Global Healthcare Conference

Indeterminate GlobeNewswire

an hour ago

Conavi Medical Reports Fiscal Third Quarter 2026 Results and Operational Highlights

Indeterminate GlobeNewswire

an hour ago

Alvotech to present at upcoming investor conferences in September

Indeterminate GlobeNewswire

an hour ago

Noah Medical Announces Collaboration to Advance Imaging in Robotic-Assisted Bronchoscopy

Indeterminate GlobeNewswire

an hour ago

SL Science Highlights New FDA Drug Master File for GDT Cell-Derived Exosomes, Expanding the Regulatory Foundation of its Platform

Indeterminate GlobeNewswire

an hour ago

Artelo Biosciences Announces Reverse Stock Split

Indeterminate GlobeNewswire

an hour ago

CytomX Therapeutics Announces FDA Fast Track Designation for Varsetatug masetecan (“Varseta-M”) for Relapsed/Refractory Metastatic Colorectal Cancer (R/R mCRC)

Indeterminate GlobeNewswire

an hour ago

Milestone Pharmaceuticals Announces Data Presented at ESC Congress 2026 on the Impact of Paroxysmal Supraventricular Tachycardia (PSVT) on Patients’ Daily Lives and Quality of Life Between Episodes

Indeterminate GlobeNewswire

an hour ago

MBX Biosciences Announces First Patient Dosed in Pivotal Phase 3 oPTimize Trial of Once-Weekly Canvuparatide in Adults with Hypoparathyroidism

Indeterminate GlobeNewswire

an hour ago

Cardurion Pharmaceuticals Announces Late-Breaking Presentation of Phase 2 Results for Tovinontrine (CRD-750), a PDE9 Inhibitor, in Heart Failure

Indeterminate GlobeNewswire

an hour ago

HealthEquity Reports Second Quarter Ended July 31, 2026 Financial Results

Indeterminate GlobeNewswire

an hour ago

Verrica Pharmaceuticals Announces Completion of Enrollment in First Pivotal Phase 3 Trial (COVE-2) Evaluating YCANTH® for the Treatment of Common Warts, with Topline Data Expected Q1 2027

Indeterminate GlobeNewswire

an hour ago

Catheter Precision Achieves Major Commercial Milestones with Cardinal Health, Johns Hopkins and the placement of the First VIVO System in Germany

Indeterminate GlobeNewswire

an hour ago

Rectify Pharmaceuticals Presents Discovery of Clinical Candidate RTY-406, a Novel Disease-Modifying Therapy for the Treatment of PSC at ACS Fall 2026 Meeting

Indeterminate GlobeNewswire